Based on LSH, CD4 expression was significantly associated with tumor location (P=0.045), tumor differentiation (P=0.007), vascular tumor thrombus (P=0.008), postoperative chemoradiotherapy (P=0.017), and CDX2 expression (P=0.011) in PDAC patients. Here, CD4 is linked to neoplasm.